Error: Could not add to watchlist. X
+ Watchlist

Biogen Inc

BIIB:US
NASDAQ GS
276.50
USD
1.27
0.46%
As of 9:30 AM EDT 3/28/2017
Open
275.59
Day Range
275.54 - 276.50
Volume
15,387
Previous Close
275.23
52Wk Range
205.43 - 307.33
1 Yr Return
18.69%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
275.59
Day Range
275.54 - 276.50
Volume
15,387
Previous Close
275.23
52Wk Range
205.43 - 307.33
1 Yr Return
18.69%
YTD Return
5.86%
Current P/E Ratio (TTM)
14.54
Earnings per Share (USD) (TTM)
18.92
Market Cap (b USD)
59.436
Shares Outstanding (m)
215.952
Price/Sales (TTM)
5.25
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.20%
% Price Change
-0.23%
Profile
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.
Address
225 Binney Street
Cambridge, MA 02142
United States
Phone
1-781-464-2000
Show More